PROSTATIC ARTERY EMBOLISATION

This adverse event was reported 16 times

These drugs are most commonly taken by patients reporting PROSTATIC ARTERY EMBOLISATION:

# Drug Count
0 OMEPRAZOLE 2
1 OMEPRAZOLE MAGNESIUM 2
2 ROSUVASTATIN 2
3 VIBEGRON 2
4 ACETAMINOPHEN 1
5 ACETAMINOPHEN 500MG 1
6 ACETAMINOPHEN TABLET EXTENDED RELEASE 1
7 ALENDRONATE SODIUM 1
8 AMLODIPINE 1
9 ARIPIPRAZOLE 1
See all common drugs associated with PROSTATIC ARTERY EMBOLISATION

PROSTATIC ARTERY EMBOLISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EPLONTERSEN 1 0.0057
1 TESTOSTERONE UNDECANOATE 1 0.0005
2 CEFIXIME 1 0.0003
3 VIBEGRON 2 0.0002
4 TAFAMIDIS 1 0.0001
5 CALCITRIOL CAPSULES 0.25 MCG 1 0.0000
6 TESTOSTERONE 1 0.0000
7 THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE 1 0.0000
8 TAPENTADOL HYDROCHLORIDE 1 0.0000
9 SILDENAFIL POWDER, 1 0.0000
See all drugs enriched for association with PROSTATIC ARTERY EMBOLISATION

PROSTATIC ARTERY EMBOLISATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antisense Oligonucleotide [EPC] 1 0.0001
1 Vitamin D3 Analog [EPC] 1 0.0000
2 beta3-Adrenergic Agonist [EPC] 2 0.0000
3 Androgen [EPC] 1 0.0000
4 BCL-2 Inhibitor [EPC] 1 0.0000
5 Tetracycline-class Drug [EPC] 1 0.0000
6 Fluoroquinolone Antibacterial [EPC] 1 0.0000
7 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
8 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
9 Opioid Agonist [EPC] 1 0.0000
See all drug classes enriched for association with PROSTATIC ARTERY EMBOLISATION